Open House Original Discount Agreements 2025-05 - Emtricitabine/Tenofovir Disoproxil/Rilpivirine (Active Ingredient Combination)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102009802

  Document Type - Tender Notices

Description - Description: TK aims to conclude discount agreements with all suitable pharmaceutical companies in accordance with Section 130c Paragraph 1 of the Social Code Book V for the active ingredient combination emtricitabine/tenofovir disoproxil/rilpivirine . The contract is concluded as part of TK's open house original procedure:Individual negotiations on the contents of the contract are not conducted, uniform conditions apply. TK does not guarantee exclusivity to individual contractual partners. The contract term is a maximum of 24 months starting on March 1, 2025. The contract ends on February 28, 2027 at the latest, regardless of the date of the contract conclusion. If the patent expires/market

Gt Ref Id - 102009802

Deadline - Feb 28, 2027